Intraday Performance and Price Movement
Gujarat Themis Biosyn Ltd opened the day with a gap down of -3.16%, setting a negative tone from the outset. The stock continued to weaken throughout the trading session, ultimately touching its intraday low at Rs 254.95, representing a decline of -7.32% from the previous close. The day’s overall price change settled at -7.12%, markedly underperforming the Pharmaceuticals & Biotechnology sector, which itself declined by -3.8% on the day.
This underperformance was also stark when compared to the broader market benchmark, the Sensex, which fell by -2.46% on the same day. Gujarat Themis Biosyn Ltd’s decline exceeded the Sensex’s drop by 4.66 percentage points, highlighting the stock’s heightened sensitivity to current market pressures.
Technical Indicators and Moving Averages
The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning signals sustained downward momentum and suggests that short-term and long-term trends remain bearish. The daily moving averages reinforce the negative sentiment, with the stock’s price consistently failing to reclaim these critical resistance levels.
Additional technical analysis reveals a predominantly bearish outlook across multiple timeframes. The Moving Average Convergence Divergence (MACD) indicator is bearish on a weekly basis and mildly bearish monthly. Bollinger Bands also indicate bearish trends both weekly and monthly, while the KST (Know Sure Thing) oscillator aligns with this negative momentum. The Dow Theory shows no clear trend weekly and a mildly bearish stance monthly. On Balance Volume (OBV) presents a mildly bearish weekly signal but a bullish monthly reading, suggesting some divergence in volume trends over different periods.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
Market Context and Sectoral Pressure
The broader market environment has been challenging, with the Sensex opening sharply lower by -800.38 points and further declining by -1,036.19 points to close at 72,696.39, down -2.46%. The index is approaching its 52-week low, currently just 1.75% above the level of 71,425.01. The Sensex’s technicals are also bearish, trading below its 50-day moving average, which itself is positioned below the 200-day moving average, a classic bearish signal. The index has recorded a three-week consecutive decline, losing -7.88% over this period.
Within this environment, the Pharmaceuticals & Biotechnology sector has not been immune to selling pressure, falling by -3.8% today. Gujarat Themis Biosyn Ltd’s sharper decline relative to its sector peers indicates specific pressures on the stock beyond general market weakness.
Relative Performance Over Time
Examining Gujarat Themis Biosyn Ltd’s performance over various time horizons reveals a pattern of underperformance relative to the Sensex. Over the past week, the stock has declined by -7.89%, compared to the Sensex’s -3.72%. The one-month performance shows a steeper fall of -23.66% versus the Sensex’s -12.72%. Over three months, the stock has dropped -37.59%, more than double the Sensex’s -15.00% decline.
Year-to-date figures are particularly notable, with Gujarat Themis Biosyn Ltd down -42.25%, significantly lagging the Sensex’s -14.70% fall. Despite this recent weakness, the stock’s longer-term performance remains strong, with gains of 160.00% over three years, 812.38% over five years, and an impressive 3,714.00% over ten years, far outpacing the Sensex’s respective returns of 25.50%, 45.24%, and 186.91%.
Is Gujarat Themis Biosyn Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Mojo Score and Rating Update
Gujarat Themis Biosyn Ltd currently holds a Mojo Score of 37.0, which corresponds to a Sell grade. This rating was downgraded from Hold on 21 Jan 2026, reflecting a reassessment of the stock’s risk and return profile. The company is classified as a small-cap within the Pharmaceuticals & Biotechnology sector, which may contribute to its heightened volatility and sensitivity to market fluctuations.
The downgrade and current rating align with the recent price action and technical signals, underscoring the challenges the stock faces in the prevailing market conditions.
Summary of Price Pressure and Market Sentiment
The sharp intraday decline in Gujarat Themis Biosyn Ltd’s share price is attributable to a combination of broader market weakness, sectoral pressure, and technical bearishness. The stock’s failure to hold above key moving averages and its underperformance relative to both sector and benchmark indices indicate sustained selling interest and cautious sentiment among market participants.
With the Sensex nearing its 52-week low and the Pharmaceuticals & Biotechnology sector also under pressure, the environment remains challenging for stocks like Gujarat Themis Biosyn Ltd. The technical indicators reinforce this view, with multiple bearish signals across daily, weekly, and monthly timeframes.
Investors observing the stock’s performance today would note the pronounced price pressure and the absence of any immediate technical support levels, which contributed to the stock touching its intraday low of Rs 254.95.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
